Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2006 | |
| Operating Expenses | 38,512 | 19,203 | 0 |
| Operating Income | -38,512 | -19,203 | N/A |
| Other Income | -1,179 | 138 | 0 |
| Pre-tax Income | -39,691 | -19,065 | 0 |
| Income Tax | 53 | 20 | N/A |
| Net Income Continuous | -39,744 | -19,085 | N/A |
| Net Income | $-39,744 | $-19,085 | $N/A |
| EPS Basic Total Ops | -44.80 | -21.50 | N/A |
| EPS Basic Continuous Ops | -44.79 | -21.51 | N/A |
| EPS Diluted Total Ops | -44.80 | -21.50 | N/A |
| EPS Diluted Continuous Ops | -44.79 | -21.51 | N/A |
| EBITDA(a) | $-38,210 | $-19,197 | $N/A |